LEADER 02813nam  2200493   450 
001 9910796639803321
005 20200923020339.0
010   $a1-68108-487-2
035   $a(CKB)4100000001041101
035   $a(MiAaPQ)EBC5145436
035   $a(Au-PeEL)EBL5145436
035   $a(CaPaEBR)ebr11466921
035   $a(OCoLC)1012345175
035   $a(NjHacI)994100000001041101
035   $a(BIP)061746924
035   $a(EXLCZ)994100000001041101
100   $a20171211h20172017  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aFrontiers in clinical drug research$hVolume 4 $eAnti infectives /$fedited by Atta-ur-Rahman
210  1$aSharjah, United Arab Emirates :$cBentham Science Publishers,$d2017.
210  4$d2017
215   $a1 online resource (259 pages)
225 0 $aFrontiers in Clinical Drug Research,$x2452-3208 ;$vVolume 4
311   $a1-68108-488-0 
320   $aIncludes bibliographical references and index.
330 8 $aFrontiers in Clinical Drug Research - Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research - Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.The fourth: Volume of this series features reviews that cover a variety of topics including: -Strategies to prolong antibiotic life-Catalytic antibodies for targeting rabies and influenza viruses-Antiviral therapies for arenaviruses-The role of steroids in viral infections-Monoclonal antibody manufacturing processes-Prevention and eradication of biofilms in medical devices
606   $aSubstance abuse$xResearch$zUnited States
610   $aAnti-Infective Agents
610   $aClinical Medicine
610   $aMedical
615  0$aSubstance abuse$xResearch
676   $a362.29072073
702   $aRahman$b Atta-ur
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910796639803321
996   $aFrontiers in clinical drug research$93675229
997   $aUNINA